NXTC insider trading — NextCure, Inc.
Over the last 90 days, insiders at NextCure, Inc. (NXTC) made 5 open-market purchases worth $1.71M and 1 open-market sale worth $185K, making them net buyers by $1.53M. The largest purchase was by Adar1 Capital Management, Llc, Schneeberger Daniel (10% Owner), who bought 292,850 shares for $1.44M on Jul 30, 2026. The largest sale was by Simcere Zaiming, Inc., Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd., Simcere Zaiming Pharmaceutical Co., Ltd., Simcere Pharmaceutical Group Ltd, Ren Jinsheng, Tang Renhong (-), who sold 30,000 shares for $185K on Aug 10, 2026.
Updated Oct 16, 2026.
Recent NXTC insider transactions
Every Form 4 filed by NextCure, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Simcere Zaiming, Inc., Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd., Simcere Zaiming Pharmaceutical Co., Ltd., Simcere Pharmaceutical Group Ltd, Ren Jinsheng, Tang Renhong | - | S · Sale | Indirect | 30,000 | $6.16 | $185K | Form 4 |
| Jul 31, 2026 | Adar1 Capital Management, Llc, Schneeberger Daniel | 10% Owner | P · Purchase | Indirect | 36,303 | $4.94 | $179K | Form 4 |
| Jul 30, 2026 | Adar1 Capital Management, Llc, Schneeberger Daniel | 10% Owner | P · Purchase | Indirect | 292,850 | $4.93 | $1.44M | Form 4 |
| Jul 29, 2026 | Adar1 Capital Management, Llc, Schneeberger Daniel | 10% Owner | P · Purchase | Indirect | 3,410 | $5.00 | $17K | Form 4 |
| Jul 28, 2026 | Adar1 Capital Management, Llc, Schneeberger Daniel | 10% Owner | P · Purchase | Indirect | 6,400 | $4.95 | $32K | Form 4 |
| Jul 27, 2026 | Adar1 Capital Management, Llc, Schneeberger Daniel | 10% Owner | P · Purchase | Indirect | 7,798 | $5.00 | $39K | Form 4 |
NXTC insider trading FAQ
Are insiders buying NXTC stock?
Yes. In the last 90 days, NextCure, Inc. insiders made 5 open-market purchases totaling $1.71M, and 1 open-market sale totaling $185K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading NXTC?
Recent buyers: Adar1 Capital Management, Llc, Schneeberger Daniel. Recent sellers: Simcere Zaiming, Inc., Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd., Simcere Zaiming Pharmaceutical Co., Ltd., Simcere Pharmaceutical Group Ltd, Ren Jinsheng, Tang Renhong.
Where does NXTC insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.